MIAMI--(BUSINESS WIRE)--DemeRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming addiction therapeutics, today announced it was awarded a $1.7 million Small Business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback